David A. Tulis

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle”.

Increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle

Metabolism(2020)10.1016/j.metabol.2020.154257

N/A

0DataRank · unranked

22 citations

Spencer G. Miller, Nicolas Verhoeven, Joshua S. Morgan, David A. Tulis, Carol A. Witczak +2 more

Protease‐Activated Receptor‐2 Differentially Regulates Vascular Smooth Muscle Cell Proliferation in Cyclic AMP‐Dependent Protein Kinase/Phosphoinositide 3‐Kinase‐Dependent Manner

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r3765

N/A

0DataRank · unranked

0 citations

Michael T. Bullock, Nathan Holland, Sean Johnson, Danielle M. Vuncannon, Joani Zary Oswald +3 more

FoxO3 normalizes Smad3-induced arterial smooth muscle cell growth

Frontiers in Physiology(2023)10.3389/fphys.2023.1136998

N/A

0DataRank · unranked

2 citations

Andrew W. Holt, Michael T. Bullock, Madison D. Williams, Cere E. Poovey, Nathan Holland +3 more

Editorial: Rising stars in vascular physiology: 2022

Frontiers in Physiology(2023)10.3389/fphys.2023.1278632

N/A

0DataRank · unranked

0 citations

Alister J. McNeish, David A. Tulis

Editorial: Animal models of vascular interventions

Frontiers in Cardiovascular Medicine(2025)10.3389/fcvm.2025.1672089

N/A

0DataRank · unranked

0 citations

David A. Tulis, Ilia Fishbein